Six factors that increase the activity of antibiotics in vivo
Tóm tắt
The traditional study of antibiotic activity in vitro obviously cannot incorporate all host factors that may increase or decrease the activity, which may be bacteriostatic and/or bactericidal. Some specific host factors which canincrease the activity of antibiotics, thus producing host-antibiotic synergy, are: 1) biotransformation of the administered antibiotic to a more active molecule, 2) pH of the infected focus, 3) elevated temperature of the host, 4) effect of heat labile serum factors on bacteria exposed to antibiotics, 5) effect of local tissue factors on antibacterial activity, and 6) effect of phagocytic cell son bacteria exposed to antibiotics. A seventh host factor, which increases the practical antibiotic effect, but not its actual activity, is concentrating mechanisms which are most conspicuous in the kidney and the liver. Conversely, host factors which maydecrease the activity of antibiotics in vivo are: 1) biotransformation (metabolism) of the antibiotic to less active forms, 2) pH of the infected focus, 3) binding to albumin or other serum or tissue components, 4) antagonism by local tissue components other than pH (e. g., bile, cations, osmolarity), 5) anaerobic conditions (low Eh), 6) nutritional factors on bacterial metabolism, 7) foreign body effect, and 8) barriers to drug entry into precise locus where bacteria dwell (e. g. abscess cavity, cerebrospinal fluid, intracellular location). These barriers do not change the actual activity of antibiotics — only their practical effects, by excluding them and thus lowering their concentrations. The same is true of a ninth factor, physiological mechanisms which remove antibiotic from systemic compartments, as in secretion of antibiotic by liver and kidney.
Tài liệu tham khảo
Abraham, E. P., Duthie, E. S. Effect of pH of the medium on activity of streptomycin and penicillin. Lancet. 1 (1946) 455–459.
Albert, A. Selective toxicity, p. 178–221. Methuen & Co. Ltd. London, 1965.
Sabath, L. D.: Synergy of antibacterial substances by apparently known mechanisms. Antimicrob. Agents chemother. 1967 (1968) 210–217.
Sabath, L. D., Gerstein, D. A., Finland, M. Enhanced activity of novobiocin against gram-negative bacilli in acid media. Antimicrob. Agents Chemother. 1968 (1969) 398–404.
Domagk, G. Ein Beitrag zur Chemotherapie der bakteriellen Infektionen, Dtsch. med. Wschr. 61 (1935) 250–253.
Eickhoff, T. C., Finland, M. Polymyxin B and colistin: In vitro activity againstPseudomonas aeruginosa. Am. J. Med. Sci. 249 (1965) 172–174.
Barnett, M., Bushby, S. R. M., Wilkinson, S. Sodium sulfomethyl derivatives of polymyxins. Br. J. Pharmacol. 23 (1964) 552–574
Nakajima, K. Structure-activity relationship of colistins. Chem. Pharm. Bull. 15 (1967) 1219–1224.
Lorian, V., Sabath, L. D. Effect of pH on the activity of erythromycin against 500 isolates of gram-negative bacilli. Appl. Microbiol. 20 (1970) 754–756.
Sabath, L. D., Gerstein, D. A., Loder, P. B., Finland, M. Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization. J. Lab. Clin. Med. 72 (1968) 916–923.
Sabath, L. D., Gerstein, D. A., Leaf, C. D., Finland, M. Increasing the usefulness of antibiotics: Treatment of infections caused by gram-negative bacilli. Clin. Pharmacol. Therap. 11 (1970) 161–169.
Harris, H. W., Murray, R., Paine, T. F., Kilham, L., Finland, M. Streptomycin treatment of urinary tract infections Am. J. Med. 2 (1947) 229–250.
Zinner, S. H., Sabath, L. D., Casey, J. I., Finland, M. Erythromycin and alkalinisation of the urine in the treatment of urinary tract infections due to gram-negative bacilli. Lancet 1 (1971) 1267–1268.
Goodell, E. W., Lopez, R., Tomasz, A. Suppression of the lytic effect of beta-lactams onE. coli and other bacteria. Proc. Nat. Acad. Sci. 73 (1976) 3293–3297.
Annear, D. I. The effect of temperature on resistance ofStaph. aureus to methicillin and some other antibiotics. Med. J. Aust. 1 (1968) 444–446.
Parker, M. T., Hewitt, J. H. Methicillin resistance inStaph. aureus. Lancet 1 (1970) 800–804.
Sabath, L. D., Wheeler, N., Laverdiere, M., Blazevic, D., Wilkinson, B. J. A new type of penicillin resistance ofStaph. aureus. Lancet 1 (1977) 443–447.
Friedman, H., Warren, G. H. Enhanced susceptibility of penicillin-resistant staphylococci to phagocytosis after in vitro incubation with low doses of nafcillin. Proc. Soc. Exp. Biol. Med. 146 (1974) 707–711.
Lorian, V., Sabath, L. D. Penicillins and cephalosporins: Differances in morphologic effects onProteus mirabilis. J. Infect. Dis. 125 (1972) 560–564.
Lorian, V., Sabath, L. D., Simionescu, M. Decrease in ribosomal density of Proteus mirabilis exposed to sub-inhibitory concentrations of ampicillin or cephalothin (38 888). Proc. Soc. Exp. Biol. Med. 149 (1975) 731–735.
Lorian, V. Some effects of subinhibitory concentrations of antibiotics on bacteria. Bull. N. Y. Acad. Med. 51 (1975) 1046–1055.
Lorian, V., Atkinson, B. Effects of subinhibitory concentrations on antibiotics on crosswalls of cocci. Antimicrob. Agents Chemother. 9 (1976) 1043–1055.
Brumfit, W., Perceival, A. Adjustment of urine pH in chemotherapy of urinary tract infections — laboratory and clinical assessment. Lancet 1 (1962) 186–190.